175 related articles for article (PubMed ID: 29599364)
1. Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.
Maehara J; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Sugimoto M; Inokuchi J; Honda H
Anticancer Res; 2018 Apr; 38(4):2377-2383. PubMed ID: 29599364
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient: An associative factor for recurrence after nephrectomy in localized renal cell carcinoma.
Nishie A; Kakihara D; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Morita K; Kubo Y; Inokuchi J; Honda H
J Magn Reson Imaging; 2016 Jan; 43(1):166-72. PubMed ID: 26082268
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival.
Veeratterapillay R; Ijabla R; Conaway D; Haslam P; Soomro N; Heer R
Clin Radiol; 2015 Dec; 70(12):1357-61. PubMed ID: 26337011
[TBL] [Abstract][Full Text] [Related]
5. Real indications for adrenalectomy in renal cell carcinoma.
Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
[TBL] [Abstract][Full Text] [Related]
6. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
8. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
9. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
[TBL] [Abstract][Full Text] [Related]
10. Small renal oncocytomas: differentiation with multiphase CT.
Gakis G; Kramer U; Schilling D; Kruck S; Stenzl A; Schlemmer HP
Eur J Radiol; 2011 Nov; 80(2):274-8. PubMed ID: 20667676
[TBL] [Abstract][Full Text] [Related]
11. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J
Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
13. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.
Kim JK; Park SY; Shon JH; Cho KS
Radiology; 2004 Mar; 230(3):677-84. PubMed ID: 14990834
[TBL] [Abstract][Full Text] [Related]
14. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.
Tsui KH; Shvarts O; Barbaric Z; Figlin R; de Kernion JB; Belldegrun A
J Urol; 2000 Feb; 163(2):437-41. PubMed ID: 10647649
[TBL] [Abstract][Full Text] [Related]
15. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
[TBL] [Abstract][Full Text] [Related]
17. Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma.
Rodriguez-Covarrubias F; Gomez-Alvarado MO; Sotomayor M; Castillejos-Molina R; Mendez-Probst CE; Gabilondo F; Feria-Bernal G
Urol Int; 2011; 86(1):47-52. PubMed ID: 20814191
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma.
Haddad AQ; Luo JH; Krabbe LM; Darwish O; Gayed B; Youssef R; Kapur P; Rakheja D; Lotan Y; Sagalowsky A; Margulis V
BJU Int; 2017 May; 119(5):741-747. PubMed ID: 28075543
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
20. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]